News/Blog

ALCOA. A framework for quality

Stan Woolen worked for FDA’s Office of Enforcement in the 1990’s, where he was tasked with a great deal of public speaking shortly after he became the Agency Bioresearch Monitoring (BIMO) Program Coordinator. He had years of experience on the ground with GCP and GLP, but found himself in need of shortcuts for helping him organize the tremendous amount of public speaking in front of

THE FUTURE OF CLINICAL RESEARCH: THE CHANGE IN THE AIR.

THE FUTURE OF CLINICAL RESEARCH: THE CHANGE IN THE AIR.
Some dread it.

Others create it.

Either way, you know it is inevitable.

Change.

The clinical research industry is no exception. Ever since James Lind’s famous scurvy trial in 1747,1 where he demonstrated the affliction could be cured by the consumption of oranges and lemons, the concepts, tenets, and processes of modern clinical research have been evolving. This is no

Hart Health Hints: November is American Diabetes Month

Join us as we recognize American Diabetes Month this November. This year, the campaign aims to raise awareness about the 29 million Americans with diabetes and to create a sense of urgency about this growing public health crisis. Approximately 1.4 million Americans over 20 are diagnosed with diabetes every year.  It remains the 7th leading cause of death, with 69,071 deaths caused by diabetes and